E. Wattel, E. Solary, X. Leleu, F. Dreyfus, A. Brion et al., A prospective study of autologous bone marrow or peripheral blood stem cell transplantation after intensive chemotherapy in myelodysplastic syndromes, Leukemia, vol.13, issue.4, pp.524-533, 1999.
DOI : 10.1038/sj.leu.2401387

J. Laporte, F. Isnard, S. Lesage, P. Fenaux, L. Douay et al., Autologous bone marrow transplantation with marrow purged by mafosfamide in seven patients with myelodysplastic syndromes in transformation (AML- MDS): a pilot study, Leukemia, vol.7, pp.2030-2033, 1993.

H. Demuynck, M. Delforge, G. Verhoef, P. Zachee, P. Vandenberghe et al., Feasibility of peripheral blood progenitor cell harvest and transplantation in patients with poor-risk myelodysplastic syndromes, British Journal of Haematology, vol.92, issue.2, pp.351-360, 1996.
DOI : 10.1046/j.1365-2141.1996.d01-1479.x

A. Carella, A. Dejana, E. Lerma, M. Podestà, F. Benvenuto et al., IN VIVO MOBILIZATION OF KARYOTyPICALLY NORMAL PERIPHERAL BLOOD PROGENITOR CELLS IN HIGH-RISK MDS, SECONDARY OR THERAPY-RELATED ACUTE MYELOGENOUS LEUKAEMIA, British Journal of Haematology, vol.95, issue.1, pp.127-157, 1996.
DOI : 10.1046/j.1365-2141.1996.7292351.x

M. Oosterveld, P. Muus, S. Suciu, C. Koller, G. Verhoef et al., Chemotherapy only compared to chemotherapy followed by transplantation in high risk myelodysplastic syndrome and secondary acute myeloid leukemia; two parallel studies adjusted for various prognostic factors, Leukemia, vol.16, issue.9, pp.1615-1636, 2002.
DOI : 10.1038/sj.leu.2402591

M. Oosterveld, S. Suciu, G. Verhoef, B. Labar, A. Belhabri et al., The presence of an HLA-identical sibling donor has no impact on outcome of patients with high-risk MDS or secondary AML (sAML) treated with intensive chemotherapy followed by transplantation: results of a prospective study of the EORTC, EBMT, SAKK and GIMEMA Leukemia Groups (EORTC study 06921), Leukemia, vol.17, issue.5, pp.859-68, 2003.
DOI : 10.1038/sj.leu.2402897

C. Gardin, P. Chaibi, T. De-revel, P. Rousselot, P. Turlure et al., Intensive chemotherapy with idarubicin, cytosine arabinoside, and granulocyte colony-stimulating factor (G-CSF) in patients with secondary and therapy-related acute myelogenous leukemia, Leukemia, vol.11, issue.1, pp.16-21, 1997.
DOI : 10.1038/sj.leu.2400536

T. De-witte, J. Hermans, J. Vossen, A. Bacigalupo, G. Meloni et al., Haematopoietic stem cell transplantation for patients with myelo-dysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT), British Journal of Haematology, vol.67, issue.3, pp.620-650, 2000.
DOI : 10.1038/sj.bmt.1701084

T. De-witte, S. Suciu, G. Verhoef, B. Labar, E. Archimbaud et al., Intensive chemotherapy followed by allogeneic or autologous stem cell transplantation for patients with myelodysplastic syndromes (MDSs) and acute myeloid leukemia following MDS, Blood, vol.98, issue.8, pp.2326-2357, 2001.
DOI : 10.1182/blood.V98.8.2326

D. Witte, T. Van-biezen, A. Hermans, J. Labopin, M. Runde et al., Autologous bone marrow transplantation for patients with myelodysplastic syndrome (MDS) or acute myeloid leukemia following MDS. Chronic and Acute Leukemia Working Parties of the European Group for Blood and Marrow Transplantation, Blood, vol.90, pp.3853-3860, 1997.

E. Wattel, E. Solary, B. Hecquet, D. Caillot, N. Ifrah et al., Quinine improves the results of intensive chemotherapy in myelodysplastic syndromes expressing P glycoprotein: results of a randomized study, British Journal of Haematology, vol.8, issue.1, pp.1015-1039, 1998.
DOI : 10.1016/0005-2736(94)90272-0
URL : https://hal.archives-ouvertes.fr/hal-00115657

B. Cheson, J. Bennett, H. Kantarjian, A. Pinto, C. Schiffer et al., Report of an international working group to standardize response criteria for myelodysplastic syndromes, Blood, vol.96, pp.3671-3675, 2000.

E. Kaplan and P. Meier, Nonparametric Estimation from Incomplete Observations, Journal of the American Statistical Association, vol.37, issue.282, pp.457-81, 1958.
DOI : 10.1214/aoms/1177731566

R. Peto and J. Peto, Asymptotically Efficient Rank Invariant Test Procedures, Journal of the Royal Statistical Society. Series A (General), vol.135, issue.2, pp.185-206, 1972.
DOI : 10.2307/2344317

D. Cox, Regression models and lifetables (with discussions), Series B, J R Stat Soc, vol.34, pp.187-220, 1972.

P. Greenberg, C. Cox, M. Lebeau, P. Fenaux, P. Morel et al., International scoring system for evaluating prognosis in myelodysplastic syndromes, Blood, vol.89, pp.2079-88, 1997.

E. Wattel, D. Botton, S. , L. Lai, J. Preudhomme et al., myelodysplastic syndromes treated with intensive chemotherapy: incidence of long-term survivors and outcome of partial responders, British Journal of Haematology, vol.98, issue.4, pp.983-91, 1997.
DOI : 10.1046/j.1365-2141.1997.2973114.x

W. Hofmann, G. Heil, C. Zander, S. Wiebe, O. Ottmann et al., Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia, Annals of Hematology, vol.83, issue.8, pp.498-503, 2004.
DOI : 10.1007/s00277-004-0889-0